Iradimed (IRMD) Cash & Equivalents Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.10% |
| Dec 31, 2025 | 0.43% |
| Sep 30, 2025 | 3.52% |
| Jun 30, 2025 | 3.12% |
| Mar 31, 2025 | 2.43% |
| Dec 31, 2024 | 3.74% |
| Sep 30, 2024 | 6.01% |
| Jun 30, 2024 | 8.40% |
| Mar 31, 2024 | 8.74% |
| Dec 31, 2023 | 12.17% |
| Sep 30, 2023 | 14.55% |
| Jun 30, 2023 | 16.52% |
| Mar 31, 2023 | 16.31% |
| Dec 31, 2022 | 26.06% |
| Sep 30, 2022 | 24.74% |
| Jun 30, 2022 | 25.43% |
| Mar 31, 2022 | 23.64% |
| Dec 31, 2021 | 28.47% |
| Sep 30, 2021 | 29.54% |
| Jun 30, 2021 | 35.52% |
| Mar 31, 2021 | 26.78% |
| Dec 31, 2020 | 20.92% |
| Sep 30, 2020 | 25.08% |
| Jun 30, 2020 | 29.61% |
| Mar 31, 2020 | 32.88% |
| Dec 31, 2019 | 35.69% |
| Sep 30, 2019 | 16.36% |
| Jun 30, 2019 | 50.06% |
| Mar 31, 2019 | 59.14% |
| Dec 31, 2018 | 62.66% |
| Sep 30, 2018 | 63.27% |
| Jun 30, 2018 | 58.05% |